Although the results of our analysis of MLH1 in EOC patients were consistent with earlier reports associating MLH1 status with CR in ovarian cancer patients, it is clear that MLH1 is not the sole determinant, and that other factors must also influence patient response and survival, in particular apoptotic dysregulation. This evidence concerns the gene MLH1 and ovarian carcinoma.